Auriga Maintains a 'Hold' on Herbalife (HLF); Beating Sustained Growth
Tweet
Share
E-mailGet Alerts HLF Hot Sheet
Price: $8.84 +2.91%
Rating Summary:
8 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
8 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Auriga maintains a 'Hold' on Herbalife (NYSE: HLF) price target of $66.00.
Analyst, Gary Albanese, said, "Herbalife reported stronger than expected results, led by significant growth in North America, Asia Pacific and South & Central America. For the quarter, the company reported EPS of $0.88 which exceeded our expectation of $0.78 and consensus of $0.81. Revenue also significantly exceeded expectations at $964.2 million compared to our estimate of $884.5 million and consensus of $892.9 million."
"Certain Market Growth Spurred the Performance. In the quarter, the company reported a 26% increase in North American revenue which was significantly above our high single digit estimate. In addition, Asia Pacific growth over 30% was about 700 bps above our estimate and South and Central American growth of 32.1% was well above our 10% estimate."
Albanese sees shares being down because HLF's revised guidance doesn't materially boost the remaining quarters.
For an analyst ratings summary and ratings history on Herbalife click here. For more ratings news on Herbalife click here.
Shares of Herbalife closed at $70.32 yesterday.
Analyst, Gary Albanese, said, "Herbalife reported stronger than expected results, led by significant growth in North America, Asia Pacific and South & Central America. For the quarter, the company reported EPS of $0.88 which exceeded our expectation of $0.78 and consensus of $0.81. Revenue also significantly exceeded expectations at $964.2 million compared to our estimate of $884.5 million and consensus of $892.9 million."
"Certain Market Growth Spurred the Performance. In the quarter, the company reported a 26% increase in North American revenue which was significantly above our high single digit estimate. In addition, Asia Pacific growth over 30% was about 700 bps above our estimate and South and Central American growth of 32.1% was well above our 10% estimate."
Albanese sees shares being down because HLF's revised guidance doesn't materially boost the remaining quarters.
For an analyst ratings summary and ratings history on Herbalife click here. For more ratings news on Herbalife click here.
Shares of Herbalife closed at $70.32 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades Feng Tay Enterprises (9910:TT) to Hold
- Banner Corporation (BANR) PT Lowered to $51 at Piper Sandler
- AvidBank Holdings Inc. (AVBH) PT Lowered to $23 at Piper Sandler
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Pacific Growth Equities, AurigaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
